Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Personalized Medicines market report explains the definition, types, applications, major countries, and major players of the Personalized Medicines market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Becton Dickinson
Pfizer
CardioDx Inc
Laboratory Corporation of America
Siemens Healthcare
Foundation Medicine
Bristol-Myers Squibb
Asuragen Inc
Abbott
Agendia NV
Qiagen
GE Healthcare
23andMe
Illumina
Amgen
Quest Diagnostics
Sanofi
3G Biotech
By Type:
PM Diagnostics
PM Therapeutics
Personalized Medical Care
Personalized Nutrition & Wellness
By End-User:
Hospitals Pharmacies
Retail Pharmacies
Dietary Care Centers
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Personalized Medicines Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Personalized Medicines Outlook to 2028- Original Forecasts
-
2.2 Personalized Medicines Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Personalized Medicines Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Personalized Medicines Market- Recent Developments
-
6.1 Personalized Medicines Market News and Developments
-
6.2 Personalized Medicines Market Deals Landscape
7 Personalized Medicines Raw Materials and Cost Structure Analysis
-
7.1 Personalized Medicines Key Raw Materials
-
7.2 Personalized Medicines Price Trend of Key Raw Materials
-
7.3 Personalized Medicines Key Suppliers of Raw Materials
-
7.4 Personalized Medicines Market Concentration Rate of Raw Materials
-
7.5 Personalized Medicines Cost Structure Analysis
-
7.5.1 Personalized Medicines Raw Materials Analysis
-
7.5.2 Personalized Medicines Labor Cost Analysis
-
7.5.3 Personalized Medicines Manufacturing Expenses Analysis
8 Global Personalized Medicines Import and Export Analysis (Top 10 Countries)
-
8.1 Global Personalized Medicines Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Personalized Medicines Export by Region (Top 10 Countries) (2017-2028)
9 Global Personalized Medicines Market Outlook by Types and Applications to 2022
-
9.1 Global Personalized Medicines Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global PM Diagnostics Consumption and Growth Rate (2017-2022)
-
9.1.2 Global PM Therapeutics Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Personalized Medical Care Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Personalized Nutrition & Wellness Consumption and Growth Rate (2017-2022)
-
9.2 Global Personalized Medicines Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Dietary Care Centers Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Personalized Medicines Market Analysis and Outlook till 2022
-
10.1 Global Personalized Medicines Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Personalized Medicines Consumption (2017-2022)
-
10.2.2 Canada Personalized Medicines Consumption (2017-2022)
-
10.2.3 Mexico Personalized Medicines Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Personalized Medicines Consumption (2017-2022)
-
10.3.2 UK Personalized Medicines Consumption (2017-2022)
-
10.3.3 Spain Personalized Medicines Consumption (2017-2022)
-
10.3.4 Belgium Personalized Medicines Consumption (2017-2022)
-
10.3.5 France Personalized Medicines Consumption (2017-2022)
-
10.3.6 Italy Personalized Medicines Consumption (2017-2022)
-
10.3.7 Denmark Personalized Medicines Consumption (2017-2022)
-
10.3.8 Finland Personalized Medicines Consumption (2017-2022)
-
10.3.9 Norway Personalized Medicines Consumption (2017-2022)
-
10.3.10 Sweden Personalized Medicines Consumption (2017-2022)
-
10.3.11 Poland Personalized Medicines Consumption (2017-2022)
-
10.3.12 Russia Personalized Medicines Consumption (2017-2022)
-
10.3.13 Turkey Personalized Medicines Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Personalized Medicines Consumption (2017-2022)
-
10.4.2 Japan Personalized Medicines Consumption (2017-2022)
-
10.4.3 India Personalized Medicines Consumption (2017-2022)
-
10.4.4 South Korea Personalized Medicines Consumption (2017-2022)
-
10.4.5 Pakistan Personalized Medicines Consumption (2017-2022)
-
10.4.6 Bangladesh Personalized Medicines Consumption (2017-2022)
-
10.4.7 Indonesia Personalized Medicines Consumption (2017-2022)
-
10.4.8 Thailand Personalized Medicines Consumption (2017-2022)
-
10.4.9 Singapore Personalized Medicines Consumption (2017-2022)
-
10.4.10 Malaysia Personalized Medicines Consumption (2017-2022)
-
10.4.11 Philippines Personalized Medicines Consumption (2017-2022)
-
10.4.12 Vietnam Personalized Medicines Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Personalized Medicines Consumption (2017-2022)
-
10.5.2 Colombia Personalized Medicines Consumption (2017-2022)
-
10.5.3 Chile Personalized Medicines Consumption (2017-2022)
-
10.5.4 Argentina Personalized Medicines Consumption (2017-2022)
-
10.5.5 Venezuela Personalized Medicines Consumption (2017-2022)
-
10.5.6 Peru Personalized Medicines Consumption (2017-2022)
-
10.5.7 Puerto Rico Personalized Medicines Consumption (2017-2022)
-
10.5.8 Ecuador Personalized Medicines Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Personalized Medicines Consumption (2017-2022)
-
10.6.2 Kuwait Personalized Medicines Consumption (2017-2022)
-
10.6.3 Oman Personalized Medicines Consumption (2017-2022)
-
10.6.4 Qatar Personalized Medicines Consumption (2017-2022)
-
10.6.5 Saudi Arabia Personalized Medicines Consumption (2017-2022)
-
10.6.6 United Arab Emirates Personalized Medicines Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Personalized Medicines Consumption (2017-2022)
-
10.7.2 South Africa Personalized Medicines Consumption (2017-2022)
-
10.7.3 Egypt Personalized Medicines Consumption (2017-2022)
-
10.7.4 Algeria Personalized Medicines Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Personalized Medicines Consumption (2017-2022)
-
10.8.2 New Zealand Personalized Medicines Consumption (2017-2022)
11 Global Personalized Medicines Competitive Analysis
-
11.1 Becton Dickinson
-
11.1.1 Becton Dickinson Company Details
-
11.1.2 Becton Dickinson Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Becton Dickinson Personalized Medicines Main Business and Markets Served
-
11.1.4 Becton Dickinson Personalized Medicines Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Pfizer
-
11.2.1 Pfizer Company Details
-
11.2.2 Pfizer Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Pfizer Personalized Medicines Main Business and Markets Served
-
11.2.4 Pfizer Personalized Medicines Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 CardioDx Inc
-
11.3.1 CardioDx Inc Company Details
-
11.3.2 CardioDx Inc Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 CardioDx Inc Personalized Medicines Main Business and Markets Served
-
11.3.4 CardioDx Inc Personalized Medicines Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Laboratory Corporation of America
-
11.4.1 Laboratory Corporation of America Company Details
-
11.4.2 Laboratory Corporation of America Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Laboratory Corporation of America Personalized Medicines Main Business and Markets Served
-
11.4.4 Laboratory Corporation of America Personalized Medicines Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Siemens Healthcare
-
11.5.1 Siemens Healthcare Company Details
-
11.5.2 Siemens Healthcare Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Siemens Healthcare Personalized Medicines Main Business and Markets Served
-
11.5.4 Siemens Healthcare Personalized Medicines Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Foundation Medicine
-
11.6.1 Foundation Medicine Company Details
-
11.6.2 Foundation Medicine Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Foundation Medicine Personalized Medicines Main Business and Markets Served
-
11.6.4 Foundation Medicine Personalized Medicines Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Bristol-Myers Squibb
-
11.7.1 Bristol-Myers Squibb Company Details
-
11.7.2 Bristol-Myers Squibb Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Bristol-Myers Squibb Personalized Medicines Main Business and Markets Served
-
11.7.4 Bristol-Myers Squibb Personalized Medicines Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Asuragen Inc
-
11.8.1 Asuragen Inc Company Details
-
11.8.2 Asuragen Inc Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Asuragen Inc Personalized Medicines Main Business and Markets Served
-
11.8.4 Asuragen Inc Personalized Medicines Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Abbott
-
11.9.1 Abbott Company Details
-
11.9.2 Abbott Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Abbott Personalized Medicines Main Business and Markets Served
-
11.9.4 Abbott Personalized Medicines Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Agendia NV
-
11.10.1 Agendia NV Company Details
-
11.10.2 Agendia NV Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Agendia NV Personalized Medicines Main Business and Markets Served
-
11.10.4 Agendia NV Personalized Medicines Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Qiagen
-
11.11.1 Qiagen Company Details
-
11.11.2 Qiagen Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Qiagen Personalized Medicines Main Business and Markets Served
-
11.11.4 Qiagen Personalized Medicines Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 GE Healthcare
-
11.12.1 GE Healthcare Company Details
-
11.12.2 GE Healthcare Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 GE Healthcare Personalized Medicines Main Business and Markets Served
-
11.12.4 GE Healthcare Personalized Medicines Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 23andMe
-
11.13.1 23andMe Company Details
-
11.13.2 23andMe Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 23andMe Personalized Medicines Main Business and Markets Served
-
11.13.4 23andMe Personalized Medicines Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Illumina
-
11.14.1 Illumina Company Details
-
11.14.2 Illumina Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Illumina Personalized Medicines Main Business and Markets Served
-
11.14.4 Illumina Personalized Medicines Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Amgen
-
11.15.1 Amgen Company Details
-
11.15.2 Amgen Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Amgen Personalized Medicines Main Business and Markets Served
-
11.15.4 Amgen Personalized Medicines Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Quest Diagnostics
-
11.16.1 Quest Diagnostics Company Details
-
11.16.2 Quest Diagnostics Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Quest Diagnostics Personalized Medicines Main Business and Markets Served
-
11.16.4 Quest Diagnostics Personalized Medicines Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Sanofi
-
11.17.1 Sanofi Company Details
-
11.17.2 Sanofi Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Sanofi Personalized Medicines Main Business and Markets Served
-
11.17.4 Sanofi Personalized Medicines Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 3G Biotech
-
11.18.1 3G Biotech Company Details
-
11.18.2 3G Biotech Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 3G Biotech Personalized Medicines Main Business and Markets Served
-
11.18.4 3G Biotech Personalized Medicines Product Portfolio
-
11.18.5 Recent Research and Development Strategies
12 Global Personalized Medicines Market Outlook by Types and Applications to 2028
-
12.1 Global Personalized Medicines Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global PM Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global PM Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Personalized Medical Care Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Personalized Nutrition & Wellness Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Personalized Medicines Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospitals Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Dietary Care Centers Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Personalized Medicines Market Analysis and Outlook to 2028
-
13.1 Global Personalized Medicines Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Personalized Medicines Consumption Forecast (2022-2028)
-
13.2.2 Canada Personalized Medicines Consumption Forecast (2022-2028)
-
13.2.3 Mexico Personalized Medicines Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Personalized Medicines Consumption Forecast (2022-2028)
-
13.3.2 UK Personalized Medicines Consumption Forecast (2022-2028)
-
13.3.3 Spain Personalized Medicines Consumption Forecast (2022-2028)
-
13.3.4 Belgium Personalized Medicines Consumption Forecast (2022-2028)
-
13.3.5 France Personalized Medicines Consumption Forecast (2022-2028)
-
13.3.6 Italy Personalized Medicines Consumption Forecast (2022-2028)
-
13.3.7 Denmark Personalized Medicines Consumption Forecast (2022-2028)
-
13.3.8 Finland Personalized Medicines Consumption Forecast (2022-2028)
-
13.3.9 Norway Personalized Medicines Consumption Forecast (2022-2028)
-
13.3.10 Sweden Personalized Medicines Consumption Forecast (2022-2028)
-
13.3.11 Poland Personalized Medicines Consumption Forecast (2022-2028)
-
13.3.12 Russia Personalized Medicines Consumption Forecast (2022-2028)
-
13.3.13 Turkey Personalized Medicines Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Personalized Medicines Consumption Forecast (2022-2028)
-
13.4.2 Japan Personalized Medicines Consumption Forecast (2022-2028)
-
13.4.3 India Personalized Medicines Consumption Forecast (2022-2028)
-
13.4.4 South Korea Personalized Medicines Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Personalized Medicines Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Personalized Medicines Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Personalized Medicines Consumption Forecast (2022-2028)
-
13.4.8 Thailand Personalized Medicines Consumption Forecast (2022-2028)
-
13.4.9 Singapore Personalized Medicines Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Personalized Medicines Consumption Forecast (2022-2028)
-
13.4.11 Philippines Personalized Medicines Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Personalized Medicines Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Personalized Medicines Consumption Forecast (2022-2028)
-
13.5.2 Colombia Personalized Medicines Consumption Forecast (2022-2028)
-
13.5.3 Chile Personalized Medicines Consumption Forecast (2022-2028)
-
13.5.4 Argentina Personalized Medicines Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Personalized Medicines Consumption Forecast (2022-2028)
-
13.5.6 Peru Personalized Medicines Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Personalized Medicines Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Personalized Medicines Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Personalized Medicines Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Personalized Medicines Consumption Forecast (2022-2028)
-
13.6.3 Oman Personalized Medicines Consumption Forecast (2022-2028)
-
13.6.4 Qatar Personalized Medicines Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Personalized Medicines Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Personalized Medicines Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Personalized Medicines Consumption Forecast (2022-2028)
-
13.7.2 South Africa Personalized Medicines Consumption Forecast (2022-2028)
-
13.7.3 Egypt Personalized Medicines Consumption Forecast (2022-2028)
-
13.7.4 Algeria Personalized Medicines Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Personalized Medicines Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Personalized Medicines Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Personalized Medicines
-
Figure of Personalized Medicines Picture
-
Table Global Personalized Medicines Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Personalized Medicines Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global PM Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Global PM Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Personalized Medical Care Consumption and Growth Rate (2017-2022)
-
Figure Global Personalized Nutrition & Wellness Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Dietary Care Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Personalized Medicines Consumption by Country (2017-2022)
-
Table North America Personalized Medicines Consumption by Country (2017-2022)
-
Figure United States Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Canada Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Mexico Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Table Europe Personalized Medicines Consumption by Country (2017-2022)
-
Figure Germany Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure UK Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Spain Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Belgium Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure France Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Italy Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Denmark Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Finland Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Norway Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Sweden Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Poland Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Russia Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Turkey Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Table APAC Personalized Medicines Consumption by Country (2017-2022)
-
Figure China Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Japan Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure India Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure South Korea Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Thailand Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Singapore Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Philippines Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Table South America Personalized Medicines Consumption by Country (2017-2022)
-
Figure Brazil Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Colombia Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Chile Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Argentina Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Peru Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Table GCC Personalized Medicines Consumption by Country (2017-2022)
-
Figure Bahrain Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Oman Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Qatar Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Table Africa Personalized Medicines Consumption by Country (2017-2022)
-
Figure Nigeria Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure South Africa Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Egypt Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure Algeria Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Table Oceania Personalized Medicines Consumption by Country (2017-2022)
-
Figure Australia Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Personalized Medicines Consumption and Growth Rate (2017-2022)
-
Table Becton Dickinson Company Details
-
Table Becton Dickinson Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Becton Dickinson Personalized Medicines Main Business and Markets Served
-
Table Becton Dickinson Personalized Medicines Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Personalized Medicines Main Business and Markets Served
-
Table Pfizer Personalized Medicines Product Portfolio
-
Table CardioDx Inc Company Details
-
Table CardioDx Inc Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table CardioDx Inc Personalized Medicines Main Business and Markets Served
-
Table CardioDx Inc Personalized Medicines Product Portfolio
-
Table Laboratory Corporation of America Company Details
-
Table Laboratory Corporation of America Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Laboratory Corporation of America Personalized Medicines Main Business and Markets Served
-
Table Laboratory Corporation of America Personalized Medicines Product Portfolio
-
Table Siemens Healthcare Company Details
-
Table Siemens Healthcare Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Siemens Healthcare Personalized Medicines Main Business and Markets Served
-
Table Siemens Healthcare Personalized Medicines Product Portfolio
-
Table Foundation Medicine Company Details
-
Table Foundation Medicine Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Foundation Medicine Personalized Medicines Main Business and Markets Served
-
Table Foundation Medicine Personalized Medicines Product Portfolio
-
Table Bristol-Myers Squibb Company Details
-
Table Bristol-Myers Squibb Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Personalized Medicines Main Business and Markets Served
-
Table Bristol-Myers Squibb Personalized Medicines Product Portfolio
-
Table Asuragen Inc Company Details
-
Table Asuragen Inc Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Asuragen Inc Personalized Medicines Main Business and Markets Served
-
Table Asuragen Inc Personalized Medicines Product Portfolio
-
Table Abbott Company Details
-
Table Abbott Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Personalized Medicines Main Business and Markets Served
-
Table Abbott Personalized Medicines Product Portfolio
-
Table Agendia NV Company Details
-
Table Agendia NV Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Agendia NV Personalized Medicines Main Business and Markets Served
-
Table Agendia NV Personalized Medicines Product Portfolio
-
Table Qiagen Company Details
-
Table Qiagen Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Qiagen Personalized Medicines Main Business and Markets Served
-
Table Qiagen Personalized Medicines Product Portfolio
-
Table GE Healthcare Company Details
-
Table GE Healthcare Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table GE Healthcare Personalized Medicines Main Business and Markets Served
-
Table GE Healthcare Personalized Medicines Product Portfolio
-
Table 23andMe Company Details
-
Table 23andMe Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table 23andMe Personalized Medicines Main Business and Markets Served
-
Table 23andMe Personalized Medicines Product Portfolio
-
Table Illumina Company Details
-
Table Illumina Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Illumina Personalized Medicines Main Business and Markets Served
-
Table Illumina Personalized Medicines Product Portfolio
-
Table Amgen Company Details
-
Table Amgen Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Personalized Medicines Main Business and Markets Served
-
Table Amgen Personalized Medicines Product Portfolio
-
Table Quest Diagnostics Company Details
-
Table Quest Diagnostics Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Quest Diagnostics Personalized Medicines Main Business and Markets Served
-
Table Quest Diagnostics Personalized Medicines Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Personalized Medicines Main Business and Markets Served
-
Table Sanofi Personalized Medicines Product Portfolio
-
Table 3G Biotech Company Details
-
Table 3G Biotech Personalized Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table 3G Biotech Personalized Medicines Main Business and Markets Served
-
Table 3G Biotech Personalized Medicines Product Portfolio
-
Figure Global PM Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PM Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Personalized Medical Care Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Personalized Nutrition & Wellness Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dietary Care Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Personalized Medicines Consumption Forecast by Country (2022-2028)
-
Table North America Personalized Medicines Consumption Forecast by Country (2022-2028)
-
Figure United States Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Personalized Medicines Consumption Forecast by Country (2022-2028)
-
Figure Germany Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Personalized Medicines Consumption Forecast by Country (2022-2028)
-
Figure China Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Personalized Medicines Consumption Forecast by Country (2022-2028)
-
Figure Brazil Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Personalized Medicines Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Personalized Medicines Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Personalized Medicines Consumption Forecast by Country (2022-2028)
-
Figure Australia Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Personalized Medicines Consumption Forecast and Growth Rate (2022-2028)
-
